CVE:NDVA Indiva (NDVA) Stock Price, News & Analysis C$0.03 -0.01 (-14.29%) As of 06/12/2024 Add Compare Share Share Stock Analysis Stock AnalysisInsider TradesBuy This Stock About Indiva Stock (CVE:NDVA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Indiva alerts:Sign Up Key Stats Today's RangeC$0.03▼C$0.0450-Day RangeC$0.03▼C$0.0352-Week RangeC$0.02▼C$0.13Volume558,384 shsAverage Volume119,038 shsMarket CapitalizationC$5.86 millionP/E RatioN/ADividend Yield4.04%Price TargetN/AConsensus RatingN/A Company OverviewIndiva Limited engages in the production, processing, and sale of cannabis and cannabis related products in Canada. It offers pre-rolls, flower, capsules, and edible and extract products under the INDIVA, Indiva Life, and Artisan Batch brands. The company produces and distributes the Bhang Chocolate, Wana Sour Gummies, Jewels Chewable Tarts, Grön edibles, and Dime Industries vape products through license agreements and partnerships. Indiva Limited is based in Ottawa, Canada.Read More… Remove Ads Receive NDVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Indiva and its competitors with MarketBeat's FREE daily newsletter. Email Address NDVA Stock News HeadlinesIndiva Ltd Average Daily Volume (3m)November 22, 2024 | investing.comSNDL Wins Bid For Indiva, Secures Major Deal To Boost Cannabis Edibles Market Share In CanadaAugust 29, 2024 | msn.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 5, 2025 | Porter & Company (Ad)Indiva Limited (NDVA-H.V)July 24, 2024 | sg.finance.yahoo.comCanadian Edibles Producer Indiva Reports Modest Q1 Results, Eyes Strong 2024 After Strategic RealignmentsMay 24, 2024 | msn.comNDVA:CA Indiva LimitedMay 4, 2024 | seekingalpha.comIndiva Limited (NDVAF) Q4 2023 Earnings Call TranscriptApril 27, 2024 | seekingalpha.comIndiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income From OperationsApril 25, 2024 | finance.yahoo.comSee More Headlines NDVA Stock Analysis - Frequently Asked Questions How have NDVA shares performed this year? Indiva's stock was trading at C$0.03 on January 1st, 2025. Since then, NDVA shares have increased by 0.0% and is now trading at C$0.03. View the best growth stocks for 2025 here. How do I buy shares of Indiva? Shares of NDVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Indiva own? Based on aggregate information from My MarketBeat watchlists, some other companies that Indiva investors own include Meta Platforms (META), Canopy Growth (CGC), 22nd Century Group (XXII), AcelRx Pharmaceuticals (ACRX), Acasti Pharma (ACST), Curaleaf (CURLF) and Fortress Biotech (FBIO). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:NDVA CIKN/A Webindiva.ca Phone888-649-6686FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-4,920,000.00 Net Margins-13.09% Pretax MarginN/A Return on Equity-544.76% Return on Assets-3.51% Debt Debt-to-Equity Ratio5,899.22 Current Ratio0.72 Quick Ratio0.52 Sales & Book Value Annual SalesC$37.57 million Price / Sales0.16 Cash FlowC$0.01 per share Price / Cash Flow5.20 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares195,490,000Free FloatN/AMarket CapC$5.86 million OptionableNot Optionable Beta1.12 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (CVE:NDVA) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indiva Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Indiva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.